These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


113 related items for PubMed ID: 3346155

  • 1. Attempts to predict the hemolytic potential of drugs in glucose-6-phosphate dehydrogenase deficiency of the Mediterranean type by an in vitro test.
    Bashan N, Peleg N, Moses SW.
    Isr J Med Sci; 1988 Jan; 24(1):61-4. PubMed ID: 3346155
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interactions of glucose-6-phosphate dehydrogenase deficiency with drug acetylation and hydroxylation reactions.
    Magon AM, Leipzig RM, Zannoni VG, Brewer GJ.
    J Lab Clin Med; 1981 Jun; 97(6):764-70. PubMed ID: 7229511
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dapsone-induced hemolytic anemia: role of glucose-6-phosphate dehydrogenase in the hemolytic response of rat erythrocytes to N-hydroxydapsone.
    Grossman S, Budinsky R, Jollow D.
    J Pharmacol Exp Ther; 1995 May; 273(2):870-7. PubMed ID: 7752092
    [Abstract] [Full Text] [Related]

  • 9. [Glucose-6-phosphate-dehydrogenase (IV) enzymopathy. Normal and pathological metabolism of erythrocytes. Mechanism of hyperhemolysis].
    Mora Lara RJ, Núñez Carril J, Rodríguez Cuartero A, Candel Delgado JM.
    Rev Clin Esp; 1973 Dec 15; 131(5):349-54. PubMed ID: 4779092
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Reduction of oxidized glutathione in normal and glucose-6-phosphate dehydrogenase deficient erythrocytes and their hemolysates.
    Rieber EE, Jaffé ER.
    Blood; 1970 Feb 15; 35(2):166-72. PubMed ID: 5414698
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Grand rounds, University Hospital. G6PD deficiency.
    Necheles TF.
    Bol Asoc Med P R; 1968 May 15; 60(5):246-61. PubMed ID: 5262255
    [No Abstract] [Full Text] [Related]

  • 16. Metabolism of the hexose monophosphate shunt in glucose-6-phosphate dehydrogenase deficiency and closely interrelated reactions.
    Jacobasch G, Bleiber R, Schönian G.
    Haematologia (Budap); 1982 Dec 15; 15(4):401-7. PubMed ID: 7186479
    [Abstract] [Full Text] [Related]

  • 17. Feprazone: absence of hemolytic effects in glucose-6-phosphate dehydrogenase-deficient subjects.
    Meloni T, Forteleoni G, Serra M, Daniotti S, Negri L, Giuntini P, Canepa L, Gaetani GF.
    J Clin Pharmacol; 1982 Dec 15; 22(8-9):418-20. PubMed ID: 7130431
    [Abstract] [Full Text] [Related]

  • 18. Catalase activity in normal and glucose-6-phosphate dehydrogenase deficient red cells.
    Ezra R, Szeinberg A, Sheba C.
    Isr J Med Sci; 1965 Jul 15; 1(4):847-50. PubMed ID: 5856129
    [No Abstract] [Full Text] [Related]

  • 19. Reduced chronic hemolysis in Mediterranean glucose-6-phosphate dehydrogenase deficiency after vitamin E therapy.
    Schulman JD, Corash L, Bartsocas C, Spielberg S, Boxer L, Sheetz M, Steinherz R, Papadatos C.
    Prog Clin Biol Res; 1979 Jul 15; 34():381-7. PubMed ID: 531063
    [No Abstract] [Full Text] [Related]

  • 20. [Systematic detection at birth of drug-induced hemolytic anemia caused by a toxic mechanism linked to an erythrocyte deficiency of glucose-6-phosphate dehydrogenase].
    Collombel C, Kissen C, Dorche C, Baltassat P, Cotte J.
    Eur J Toxicol; 1970 Jul 15; 3(1):42-8. PubMed ID: 5520461
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.